机构

• 上海药物研究所 [19]
• 合肥物质科学研究院 [10]
• 水生生物研究所 [4]
• 上海应用物理研究所 [4]
• 昆明植物研究所 [3]
• 自动化研究所 [3]
• 更多

采集方式

• OAI收割 [55]
• iSwitch采集 [5]

内容类型

• 期刊论文 [59]
• 学位论文 [1]

发表日期

• 2023 [5]
• 2022 [15]
• 2021 [8]
• 2020 [4]
• 2019 [4]
• 2018 [6]
• 更多

学科主题

• Pharmacolo... [3]
• Cell Biolo... [1]
• Fisheries;... [1]
• Research &... [1]
• Science & ... [1]

筛选

浏览/检索结果: 共60条，第1-10条 帮助 条数/页： 5101520253035404550556065707580859095100 排序方式： 请选择提交时间升序提交时间降序发表日期升序发表日期降序题名升序题名降序作者升序作者降序 Breaking Tumor Immunosuppressive Network by Regulating Multiple Nodes with Triadic Drug Delivery Nanoparticles 期刊论文  OAI收割 ACS NANO, 2023, 卷号: 17, 期号: 18, 页码: 17826-17844 作者:  Yan, Wenlu;  Li, Yu;  Zou, Yiting;  Zhu, Runqi;  Wu, Ting   |  收藏  |  浏览/下载：7/0  |  提交时间：2023/12/08 triple-negative breast cancer  antitumor immunity  tumor-associated macrophages  myeloid-derived suppressorcells  immune network  nanoparticle   Treating relapsed/refractory mature T- and NK-cell neoplasms with tislelizumab: a multicenter open-label phase 2 study 期刊论文  OAI收割 BLOOD ADVANCES, 2023, 卷号: 7 作者:  Bachy, Emmanuel;  Savage, Kerry J.;  Huang, Huiqiang;  Kwong, Yok-Lam;  Gritti, Giuseppe   |  收藏  |  浏览/下载：16/0  |  提交时间：2023/11/10 Nanovesicles loaded with a TGF-& beta; receptor 1 inhibitor overcome immune resistance to potentiate cancer immunotherapy 期刊论文  OAI收割 NATURE COMMUNICATIONS, 2023, 卷号: 14, 期号: 1, 页码: 18 作者:  Zhou, Mengxue;  Wang, Jiaxin;  Pan, Jiaxing;  Wang, Hui;  Huang, Lujia   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Aurora A kinase inhibition compromises its antitumor efficacy by elevating PD-L1 expression 期刊论文  OAI收割 JOURNAL OF CLINICAL INVESTIGATION, 2023, 卷号: 133, 期号: 9, 页码: 12 作者:  Wang, Xiaobo;  Huang, Jing;  Liu, Fenglin;  Yu, Qian;  Wang, Ruina   |  收藏  |  浏览/下载：19/0  |  提交时间：2023/10/17 Combined Use of Immune Checkpoint Inhibitors and Phytochemicals as a Novel Therapeutic Strategy against Cancer 期刊论文  OAI收割 JOURNAL OF CANCER, 2023, 卷号: 14, 期号: 12, 页码: 2315-2328 作者:  Luo, LingJie;  Lin, Caiji;  Wang, Pengfei;  Cao, Danli;  Lin, Yiru   |  收藏  |  浏览/下载：11/0  |  提交时间：2023/10/17 Immune checkpoint inhibitor  Phytochemicals  Combination therapy  Immune-related adverse events  Predictive biomarker  Gut microbiota   Redox Dyshomeostasis with Dual Stimuli-Activatable Dihydroartemisinin Nanoparticles to Potentiate Ferroptotic Therapy of Pancreatic Cancer 期刊论文  OAI收割 SMALL METHODS, 2022, 页码: 13 作者:  Wang, Yingjie;  Chen, Fangmin;  Zhou, Huiling;  Huang, Lujia;  Ye, Jiayi   |  收藏  |  浏览/下载：20/0  |  提交时间：2023/04/10 combinatory therapy  dual stimuli-responsive  ferroptosis  immunotherapy  pancreatic cancer   Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors 期刊论文  OAI收割 BMC Medicine, 2022, 卷号: 20, 期号: 1 作者:  Zhang,Pei;  Du,Yang;  Bai,Hua;  Wang,Zhijie;  Duan,Jianchun   |  收藏  |  浏览/下载：19/0  |  提交时间：2022/11/21 Tucidinostat  Tumor microenvironment  PD-L1  CCL5  Solid tumor   Self-Cooperative Prodrug Nanovesicles Migrate Immune Evasion to Potentiate Chemoradiotherapy in Head and Neck Cancer 期刊论文  OAI收割 ADVANCED SCIENCE, 2022, 页码: 13 作者:  Zhu, Yun;  Zhang, Shunan;  Lai, Yi;  Pan, Jiaxing;  Chen, Fangmin   |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/13 chemoradiotherapy  cooperative therapy  head and neck cancer  immune evasion  immunogenic cell death   Pulmonary Salivary Gland Tumor, Mucoepidermoid Carcinoma: A Literature Review 期刊论文  OAI收割 JOURNAL OF ONCOLOGY, 2022, 卷号: 2022 作者:  Hu, Shumin;  Gong, Jiali;  Zhu, Xiu;  Lu, Hongyang   |  收藏  |  浏览/下载：24/0  |  提交时间：2022/12/23 Repurposing of the FGFR inhibitor AZD4547 as a potent inhibitor of necroptosis by selectively targeting RIPK1 期刊论文  OAI收割 ACTA PHARMACOLOGICA SINICA, 2022 作者:  Wang, Zuo-wei;  Zou, Feng-ming;  Wang, Ao-li;  Yang, Jing;  Jin, Rui   |  收藏  |  浏览/下载：30/0  |  提交时间：2022/12/22 AZD4547  RIPK1  inhibitors  SIRS model  anti-necroptosis